PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 378.50
Bid: 378.00
Ask: 379.50
Change: -1.50 (-0.39%)
Spread: 1.50 (0.397%)
Open: 385.00
High: 385.00
Low: 374.00
Prev. Close: 380.00
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

16 May 2014 07:00

RNS Number : 2826H
Tyman PLC
16 May 2014
 



TYMAN PLC

("Tyman" or the "Group" or the "Company")

 

Interim Management Statement

 

Tyman plc ("Tyman" or the "Group"), the international supplier of components to the door and window industry, issues the following Interim Management Statement for the period from 1 January 2014 to date, ahead of the Group's Annual General Meeting being held today at 10.30 a.m. at the offices of Pinsent Masons in London.

 

Trading Update

Trading in the first four months of 2014 has been in line with management's expectations, noting that this period typically sees lower seasonal levels of activity in our Northern Hemisphere end-markets.

Revenues from continuing operations ("Revenues") for the period ended 30 April 2014 increased by approximately 34 per cent. compared with the corresponding period in 2013, reflecting the increased size of the Group following the acquisitions of Truth and Vedasil.

Excluding the benefit of acquisitions, reported Revenues increased by approximately 5 per cent. and on a constant currency, like for like basis, Revenues increased by approximately 10 per cent, the difference reflecting the continued strengthening of Sterling against international currencies.

 

Amesbury and Truth

In North America, the Amesbury and Truth businesses have seen an encouraging start to 2014 with revenues running slightly ahead of 2013 in the four months to April despite the harsh weather conditions seen across the United States. The Canadian market has also seen a solid start to 2014 with improved market sentiment and is trading ahead of early 2013 comparatives.

The integration of Amesbury and Truth continues to progress well under the leadership of the combined management team with a number of key initiatives put in place since the start of the year and delivery of targeted synergies on schedule.

 

Grouphomesafe

In the UK, as expected, Grouphomesafe has seen the recovery in the market that started at the end of Q1 2013 continue into 2014. Our components business has seen significant increases in demand from both OEM fabricators and distributors with Fab & Fix and ERA in particular seeing encouraging growth.

The first quarter of 2013 was particularly weak in the UK so year on year growth is expected to moderate somewhat across the balance of the year as comparatives become tougher, however the outlook for Grouphomesafe and the UK market remains positive.

 

Schlegel International

Our International Building Products business saw modest growth overall in European markets with sales into Eastern Europe and Scandinavia performing better year to date than in 2013. Western and Southern European markets remain mixed, although our sales into Germany have seen a stronger start to 2014, and in Italy we continue to take market share.

Australia, Singapore and Brazil have each started the year well and the integration of Vedasil is progressing according to schedule.

 

North American Footprint Evaluation

The first phase of the North American footprint evaluation has been completed by the new Amesbury and Truth management team and, as part of that process, the Atlanta extrusion facility has been identified as being surplus to the Group's requirements.

Production at this site will be relocated to our Minnesota extrusion facility by the end of the summer, reflecting the focus of our extrusion business on high value added engineered component manufacture. The cash costs of closure are estimated at approximately US$0.5 million.

The Group will continue to service its national extrusion customer base from its other North American plants, utilising the extensive Amesbury and Truth distribution network.

Further evaluation of the North American manufacturing footprint will continue during the remainder of 2014 as we look to improve the effectiveness of the Amesbury and Truth operations and position the business for long term growth.

 

Financial Position of Tyman

The Group's financial position remains strong. Other than the normal seasonal increase in working capital, and the capital outlay to acquire Vedasil, there has been no significant change to the Group's financial position since the last year end.

 

North American Site Visit

Tyman will host an Investor and Analyst site visit to its facilities in Owatonna, Minnesota and Sioux Falls, South Dakota between 19 and 21 May 2014. Presentation materials will be posted on the Group's website.

No material new information will be disclosed in the presentations and there will be no statements on current trading.

 

Half Year Results Announcement

Tyman will issue its half year results for the six months ending 30 June 2014 on Tuesday 29 July 2014.

 

Louis Eperjesi, Chief Executive of Tyman, commented:

"We have had an encouraging first four months to the year, consistent with our expectations for the year as a whole. Continued recovery in our key end markets, combined with share gains and the delivery of targeted synergy benefits in North America underpin our confidence for the future."

 

16 May 2014

 

Enquiries

Tyman plc

0207 976 8000

Louis Eperjesi

www.tymanplc.com

James Brotherton

MHP

020 3128 8100

Reg Hoare

Jamie Ricketts

Nick Hayns

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGMKNKFGDZM
Date   Source Headline
10th May 20214:41 pmRNSHolding(s) in Company
6th May 20217:00 amRNSTrading Update
5th May 20217:00 amRNSDirector/PDMR Shareholding
30th Apr 20218:23 amRNSHolding(s) in Company
23rd Apr 202112:31 pmRNSNotice of Capital Markets Day
16th Apr 20219:56 amRNSNotice of AGM
9th Apr 20216:14 pmRNSHolding(s) in Company
23rd Mar 202110:59 amRNSHolding(s) in Company
22nd Mar 20213:57 pmRNSHolding(s) in Company
19th Mar 20213:05 pmRNSHolding(s) in Company
4th Mar 202111:36 amRNSDividend Declaration
4th Mar 20217:00 amRNSFinal Results
30th Dec 20209:45 amRNSDirector/PDMR Shareholding - Replacement
24th Dec 20209:45 amRNSDirector/PDMR Shareholding
10th Dec 20202:56 pmRNSHolding(s) in Company
8th Dec 20207:00 amRNSTrading Statement
2nd Nov 20206:12 pmRNSTotal Voting Rights
29th Oct 20206:04 pmRNSHolding(s) in Company
26th Oct 20204:05 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSTrading and COVID-19 Update
5th Oct 20205:45 pmRNSHolding(s) in Company
1st Oct 20204:00 pmRNSDirector/PDMR Shareholding
1st Oct 20204:00 pmRNSDirector/PDMR Shareholding
17th Sep 20207:00 amRNSDirectorate Changes
28th Aug 20204:20 pmRNSHolding(s) in Company
28th Aug 20204:20 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSHolding(s) in Company
4th Aug 20207:00 amRNSHolding(s) in Company
29th Jul 20205:00 pmRNSHolding(s) in Company
29th Jul 20205:00 pmRNSHolding(s) in Company
28th Jul 20207:00 amRNSHalf-year Report
27th Jul 20202:03 pmRNSHolding(s) in Company
27th Jul 20202:02 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
21st May 20203:30 pmRNSHolding(s) in Company
20th May 202010:40 amRNSResult of AGM
20th May 20207:00 amRNSAnnual General Meeting Trading and COVID-19 Update
4th May 20204:14 pmRNSDirector/PDMR Shareholding
17th Apr 20202:33 pmRNSHolding(s) in Company
8th Apr 20207:00 amRNSNotice of AGM
3rd Apr 20203:07 pmRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSCOVID-19 and Dividend Update
26th Mar 20207:00 amRNSDirector/PDMR Shareholding
20th Mar 20204:31 pmRNSDirector/PDMR Shareholding
17th Mar 20204:37 pmRNSPrice Monitoring Extension
10th Mar 202011:46 amRNSHolding(s) in Company
6th Mar 20205:28 pmRNSHolding(s) in Company
5th Mar 202012:23 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.